Clinical Trials Logo

Refractory Major Depressive Disorder clinical trials

View clinical trials related to Refractory Major Depressive Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT03610048 Not yet recruiting - Clinical trials for Refractory Major Depressive Disorder

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Start date: August 2018
Phase: Phase 3
Study type: Interventional

This study will assess the long-term safety and tolerability of ALKS 5461 as an adjunctive treatment for refractory MDD.